Metabolomic research - serum sample analysis in pancreatic cancer

Ended Purchase Order Awarded Last action

Contract number
HHSN261201600682P
Awardee
Awarding agency
Obligated
$177,500

Award facts

Opportunity
Contract value 100% obligated
$177,500.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Not Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Rockville, MD 20850, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action 1 $0
Original award $177,500

About this award

The National Cancer Institute awarded a purchase order to Metabolon, Inc. valued at $177,500 for metabolomic research and serum sample analysis in pancreatic cancer, with an award date of September 16, 2016 and completion date of September 15, 2018. Work is performed at Metabolon's Rockville, Maryland facility. The order covers analysis and metabolic profiling of serum samples using ultra-high performance liquid chromatography and tandem mass spectrometry. Metabolon is a self-certified small disadvantaged business.

Quick answers

Who was awarded contract HHSN261201600682P?

HHSN261201600682P was awarded to Metabolon, Inc. by National Cancer Institute (National Institutes of Health) on September 16, 2016.

How much is contract HHSN261201600682P worth?

The government has obligated $177,500 on HHSN261201600682P.

Was contract HHSN261201600682P competed?

The extent of competition for HHSN261201600682P was not competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award